135 related articles for article (PubMed ID: 31536667)
1. Radioresistant laryngeal cancers upregulate type 1 IGF receptor and exhibit increased cellular dependence on IGF and EGF signalling.
Qureishi A; Rieunier G; Shah KA; Aleksic T; Winter SC; Møller H; Macaulay VM
Clin Otolaryngol; 2019 Nov; 44(6):1026-1036. PubMed ID: 31536667
[TBL] [Abstract][Full Text] [Related]
2. The value of insulin-like growth factor-1 receptor for predicting early glottic carcinoma response to radiotherapy.
Matsumoto F; Ohba S; Fujimaki M; Ikeda K
Auris Nasus Larynx; 2016 Aug; 43(4):440-5. PubMed ID: 26739949
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of EGFR or IGF-1R signaling enhances radiation response in head and neck cancer models but concurrent inhibition has no added benefit.
Raju U; Molkentine DP; Valdecanas DR; Deorukhkar A; Mason KA; Buchholz TA; Meyn RE; Ang KK; Skinner H
Cancer Med; 2015 Jan; 4(1):65-74. PubMed ID: 25355701
[TBL] [Abstract][Full Text] [Related]
4. The Prognostic Significance of IGF-1R and the Predictive Risk Value of Circulating IGF-1 in Tunisian Patients with Laryngeal Carcinoma.
Ben Elhadj M; Goucha A; Fourati A; Adouni O; Dhambri S; Hsairi M; El May MV; Mokni Baizig N
Cancer Invest; 2020 May; 38(5):289-299. PubMed ID: 32308049
[TBL] [Abstract][Full Text] [Related]
5. Targeting cancer stem cell plasticity through modulation of epidermal growth factor and insulin-like growth factor receptor signaling in head and neck squamous cell cancer.
Leong HS; Chong FT; Sew PH; Lau DP; Wong BH; Teh BT; Tan DS; Iyer NG
Stem Cells Transl Med; 2014 Sep; 3(9):1055-65. PubMed ID: 25024430
[TBL] [Abstract][Full Text] [Related]
6. Co-inhibition of epidermal growth factor receptor and insulin-like growth factor receptor 1 enhances radiosensitivity in human breast cancer cells.
Li P; Veldwijk MR; Zhang Q; Li ZB; Xu WC; Fu S
BMC Cancer; 2013 Jun; 13():297. PubMed ID: 23777562
[TBL] [Abstract][Full Text] [Related]
7. Potential role of microvessel density in predicting radiosensitivity of T1 and T2 stage laryngeal squamous cell carcinoma treated with radiotherapy.
Kamijo T; Yokose T; Hasebe T; Yonou H; Sasaki S; Hayashi R; Ebihara S; Miyahara H; Hosoi H; Ochiai A
Clin Cancer Res; 2000 Aug; 6(8):3159-65. PubMed ID: 10955798
[TBL] [Abstract][Full Text] [Related]
8. Systemic analysis of different colorectal cancer cell lines and TCGA datasets identified IGF-1R/EGFR-PPAR-CASPASE axis as important indicator for radiotherapy sensitivity.
Chen L; Zhu Z; Gao W; Jiang Q; Yu J; Fu C
Gene; 2017 Sep; 627():484-490. PubMed ID: 28687332
[TBL] [Abstract][Full Text] [Related]
9. Bcl-2 expression predicts radiotherapy failure in laryngeal cancer.
Nix P; Cawkwell L; Patmore H; Greenman J; Stafford N
Br J Cancer; 2005 Jun; 92(12):2185-9. PubMed ID: 15928664
[TBL] [Abstract][Full Text] [Related]
10. A ligand-based and enediyne-energized bispecific fusion protein targeting epidermal growth factor receptor and insulin-like growth factor-1 receptor shows potent antitumor efficacy against esophageal cancer.
Cao HY; Guo XF; Zhu XF; Li SS; Zhen YS
Oncol Rep; 2017 Jun; 37(6):3329-3340. PubMed ID: 28498434
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor receptor expression in laryngeal cancer predicts the effect of hypoxia modification as an additive to accelerated radiotherapy in a randomised controlled trial.
Nijkamp MM; Span PN; Terhaard CH; Doornaert PA; Langendijk JA; van den Ende PL; de Jong M; van der Kogel AJ; Bussink J; Kaanders JH
Eur J Cancer; 2013 Oct; 49(15):3202-9. PubMed ID: 23867129
[TBL] [Abstract][Full Text] [Related]
12. Laryngeal carcinoma lymph node metastasis and disease-free survival correlate with MASPIN nuclear expression but not with EGFR expression: a series of 108 cases.
Marioni G; Staffieri A; Bertolin A; Giacomelli L; D'Alessandro E; Ottaviano G; Accordi D; Stramare R; de Filippis C; Blandamura S
Eur Arch Otorhinolaryngol; 2010 Jul; 267(7):1103-10. PubMed ID: 20052590
[TBL] [Abstract][Full Text] [Related]
13. Impact of epidermal growth factor receptor, mesenchymal-epithelial transition factor, and insulin-like growth factor receptor 1 expression on survival of patients with oral and oropharyngeal cancer.
Perisanidis C; Wrba F; Brandstetter A; Kornek G; Mitchell D; Seemann R; Selzer E; Ewers R; Filipits M
Br J Oral Maxillofac Surg; 2013 Apr; 51(3):234-40. PubMed ID: 22889668
[TBL] [Abstract][Full Text] [Related]
14. CircRASSF2 promotes laryngeal squamous cell carcinoma progression by regulating the miR-302b-3p/IGF-1R axis.
Tian L; Cao J; Jiao H; Zhang J; Ren X; Liu X; Liu M; Sun Y
Clin Sci (Lond); 2019 May; 133(9):1053-1066. PubMed ID: 30992382
[No Abstract] [Full Text] [Related]
15. Expression of insulin-like growth factor 1 receptor (IGF-1R) predicts poor responses to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in non-small cell lung cancer patients harboring activating EGFR mutations.
Yeo CD; Park KH; Park CK; Lee SH; Kim SJ; Yoon HK; Lee YS; Lee EJ; Lee KY; Kim TJ
Lung Cancer; 2015 Mar; 87(3):311-7. PubMed ID: 25617986
[TBL] [Abstract][Full Text] [Related]
16. IGF-1R expression predicts clinical outcome in patients with locally advanced oral squamous cell carcinoma.
Lara PC; Bordón E; Rey A; Moreno M; Lloret M; Henríquez-Hernández LA
Oral Oncol; 2011 Jul; 47(7):615-9. PubMed ID: 21640634
[TBL] [Abstract][Full Text] [Related]
17. [Relation between epidermal growth factor receptor (EGFR) and p53 expression and radiocurability of laryngeal squamous cell cancer].
Dupla D; Fraczek M; Woźniak Z; Krecicki T
Otolaryngol Pol; 2009; 63(3):249-55. PubMed ID: 19886531
[TBL] [Abstract][Full Text] [Related]
18. Curcumin potentiates laryngeal squamous carcinoma radiosensitivity via NF-ΚB inhibition by suppressing IKKγ expression.
Deng XZ; Geng SS; Luo M; Chai JJ; Xu Y; Chen CL; Qiu L; Ke Q; Duan QW; Song SM; Shen L; Luo ZG
J Recept Signal Transduct Res; 2020 Dec; 40(6):541-549. PubMed ID: 32515250
[No Abstract] [Full Text] [Related]
19. Laryngeal carcinoma prognosis after postoperative radiotherapy correlates with CD105 expression, but not with angiogenin or EGFR expression.
Marioni G; Blandamura S; Loreggian L; Koussis H; Lionello M; Giacomelli L; Fasanaro E; Lovato A; Staffieri A
Eur Arch Otorhinolaryngol; 2011 Dec; 268(12):1779-87. PubMed ID: 21842202
[TBL] [Abstract][Full Text] [Related]
20. Local recurrence in head and neck cancer: relationship to radiation resistance and signal transduction.
Gupta AK; McKenna WG; Weber CN; Feldman MD; Goldsmith JD; Mick R; Machtay M; Rosenthal DI; Bakanauskas VJ; Cerniglia GJ; Bernhard EJ; Weber RS; Muschel RJ
Clin Cancer Res; 2002 Mar; 8(3):885-92. PubMed ID: 11895923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]